My Companies
Notification
Account
Tanuku API facility's USFDA inspection of 13-17 July 2026 classified as Official Action Indicated. Company says no impact on business continuity or existing product supplies and will work with USFDA on compliance. Context: breaks clean-inspection run after TGA observations.
Wanbury Secures ANVISA Approval For Flagship Metformin HCl In Brazil
Wanbury Wins Rs15 Crore Mexico Tender Expands Saudi Metformin Business
Wanbury Secures Rivaroxaban EDQM Approval And Two USFDA DMF Clearances
Wanbury Tanuku Facility Receives USFDA Form 483 With Six Observations
Wanbury Board Approves Early Redemption of ₹180 Crore NCDs